Back

Which should we choose as the anticoagulants for atrial fibrillation patients with coronary stenting? ;Warfarin v.s. Non-vitamin K-antagonist oral anticoagulants

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 5 - PCI - Adjunctive drug therapy PCI - Adjunctive drug therapy ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Hiroshi Koiwaya

Miyazaki Medical Association Hospital, Miyazaki (Japan)

13 More presentations in this session

Presentation thumbnail
High-dose statin pretreatment decreases cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: a meta-analysis of eighteenrandomized controlled trials
Associate Professor B. Zheng (Beijing, CN)
Abstract Slides
Presentation thumbnail
Dual therapy versus Triple therapy in patients undergoing coronary stent implantation: a systematic review and meta-analysis
Doctor S. Cornara (Savona, IT)
Abstract Slides
Presentation thumbnail
Prolonged dual antiplatelet therapy did not affect survival after left main artery stenting (Hong Kong Left Main Stenting Registry)
Doctor C. Cheung (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Trimetazidine modified release therapy in post-myocardial infarction patients with multivessel disease having undergone incomplete revascularization: results of two years of follow up
Professor Y. Lopatin (Volgograd, RU)
Abstract
Presentation thumbnail
Effects of Clopidogrel and proton pump inhibitors on cardiovascular events in patients with type 2 diabetes mellitus after bare metal stent implantation: a nationwide cohort study
Doctor C. Chen (Taipei, TW)
Abstract Slides

Access the full session

Session thumbnail
Poster session 5 - PCI - Adjunctive drug therapy

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources